Stefan Pöhlmann
@snpoehlm.bsky.social
Viruses & Proteases, Head of Infection Biology Unit, Deutsches Primatenzentrum, @primatenzentrum.bsky.social, Decoding viral entry, Tracking SARS-CoV-2 variants, https://linktr.ee/snpoehlm, Views are my own
All BA.3.2.2 - 1 from Rhineland-Palatinate, 3 from North Rhine–Westphalia. Roughly 4% of all sequences reported
A small but unexpected comeback. 🎃
A small but unexpected comeback. 🎃
November 12, 2025 at 5:58 PM
All BA.3.2.2 - 1 from Rhineland-Palatinate, 3 from North Rhine–Westphalia. Roughly 4% of all sequences reported
A small but unexpected comeback. 🎃
A small but unexpected comeback. 🎃
No info yet on severity. Antibody profile in the WA population might be particularly favorable for BA.3.2.
November 12, 2025 at 4:31 PM
No info yet on severity. Antibody profile in the WA population might be particularly favorable for BA.3.2.
Reposted by Stefan Pöhlmann
So we have four branches of BA.3.2 circulating now
two BA.3.2.1 related each other but distinct and two BA.3.2.2 related but distinct.
My take about this is that both lineages are enough tuned to not disappear , with BA.3.2.2 having the potential of expand further.
two BA.3.2.1 related each other but distinct and two BA.3.2.2 related but distinct.
My take about this is that both lineages are enough tuned to not disappear , with BA.3.2.2 having the potential of expand further.
November 1, 2025 at 1:10 PM
So we have four branches of BA.3.2 circulating now
two BA.3.2.1 related each other but distinct and two BA.3.2.2 related but distinct.
My take about this is that both lineages are enough tuned to not disappear , with BA.3.2.2 having the potential of expand further.
two BA.3.2.1 related each other but distinct and two BA.3.2.2 related but distinct.
My take about this is that both lineages are enough tuned to not disappear , with BA.3.2.2 having the potential of expand further.
Infectivity comparable to LP.8.1. Evades neutralization by pre-2022 plasma with very high efficiency. Strong evasion persists for 2024 samples, but is less pronounced for 2025 samples.
October 31, 2025 at 9:21 PM
Infectivity comparable to LP.8.1. Evades neutralization by pre-2022 plasma with very high efficiency. Strong evasion persists for 2024 samples, but is less pronounced for 2025 samples.